Status:
UNKNOWN
STABLE (Strength Training and Balance Leg Exercise) Study
Lead Sponsor:
University of Saskatchewan
Collaborating Sponsors:
Saskatchewan Health Research Foundation
Conditions:
Neoplasms
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Falls are a major health concern amongst older adults with cancer, and are often related to decreased physical strength due to effects of cancer and its treatments. Ample evidence demonstrates the ben...
Detailed Description
Hypothesis: A remotely delivered, 3-month resistance and balance training program will result in an increase in lower body strength, improvement in balance, as well as a lower fall rate compared to co...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adults aged 65 or above;
- living in the community;
- have a confirmed diagnosis of any stage of lung, breast, prostate, or colorectal cancer; - currently receiving, starting or have completed systemic anti-cancer therapy;
- life-expectancy of at least 9 months (in consideration of the measurement period of the study and also avoid burdening patients who are near the end-stage of their disease); and - completed the PAR-Q screening or have approval of their treating physician.
- Exclusion criteria:
- presence of brain metastases;
- presence of unstable metastases as per treating physician (e.g., bone metastasis in a weight-bearing area, recent bone fracture);
- presence of any conditions that would potentially interfere with their ability to carry out the exercise interventions (e.g., mobility impairment, poorly controlled pain, severe vision/hearing loss, severe arthritis that limits ambulation, left-sided heart failure, neurological or musculoskeletal conditions);
- self-reported history of light-headedness during physical activities; syncopal episodes within the past month; and
- participation in any form of structured exercise program (that are at least 30 minutes per week) at the time of consent.
Exclusion
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04518098
Start Date
January 1 2023
End Date
November 30 2023
Last Update
May 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Saskatchewan, Canada